Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

Clinical tools to guide in the appropriate treatment selection in immunoglobulin light chain (AL) amyloidosis are not well developed. We evaluated the response and outcome for various regimens at first-line treatment (n=681) and first progression (n=240) stratified by the immunoparesis status at dia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Muchtar, Eli, Dispenzieri, Angela, Kumar, Shaji K., Dingli, David, Lacy, Martha Q., Buadi, Francis K., Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Chakraborty, Rajshekhar, Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5060027/
https://ncbi.nlm.nih.gov/pubmed/27479823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.147041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados